The Claim
In transfusion-dependent thalassemia (TDT) patients, Hemoglobin A1c (HbA1c) measurements obtained via high-performance liquid chromatography (HPLC) show significant discordance with fasting glucose levels, as 85.7% of patients have diabetic-range HbA1c (>6.4%) while 74.3% have normal fasting glucose (<100 mg/dL), indicating poor alignment between these two glycemic markers.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with a blood disorder who need regular transfusions, the common blood sugar test (HbA1c) often says they have high blood sugar, but their fasting blood sugar test says it's normal — so the two tests don’t match up well.
See the scientific wording
Hemoglobin A1c (HbA1c) measurement by high-performance liquid chromatography (HPLC) is not reliably aligned with fasting glucose levels in transfusion-dependent thalassemia (TDT) patients, as evidenced by 85.7% having diabetic-range HbA1c (>6.4%) while 74.3% have normal fasting glucose (<100 mg/dL), indicating significant discordance between these two glycemic markers.
What the research says
1 studyThe study found that most thalassemia patients had high HbA1c but normal blood sugar, showing HbA1c doesn't reflect true sugar levels in these patients.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.